Verano Holdings (VRNO) Change in Accured Expenses (2021 - 2026)

Verano Holdings' (VRNO) quarterly Change in Accured Expenses came in at -$15.7 million in Q1 2026, down 74.1% year-on-year from -$60.7 million in Q1 2025, and down 489.04% on a QoQ basis from $4.0 million in Q4 2025.

Verano Holdings (VRNO) Change in Accured Expenses (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Change in Accured Expenses data on file, last reported at -$15.7 million in Q1 2026.

  • On a quarterly basis, Change in Accured Expenses fell 74.1% year-over-year to -$15.7 million in Q1 2026; TTM through Mar 2026 was -$12.2 million, a 31.07% increase from a year earlier, with the FY2025 full-year figure at -$5.5 million, up 67.69% from the prior year.
  • Change in Accured Expenses for Q1 2026 stood at -$15.7 million, down from $4.0 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for VRNO reached as high as $32.2 million in Q4 2022 and fell as low as -$18.0 million in Q3 2022.
  • Historically, Change in Accured Expenses has averaged -$1.5 million across 5 years, with a median of -$5.2 million in 2023.
  • On a YoY basis, Change in Accured Expenses climbed as much as 203.91% in 2022 and fell as far as 1092.79% in 2022.
  • Year by year, Change in Accured Expenses stood at $32.2 million in 2022, then declined by 19.29% to $26.0 million in 2023, then slumped by 139.64% to -$10.3 million in 2024, then soared by 139.21% to $4.0 million in 2025, then plunged by 489.04% to -$15.7 million in 2026.
  • Per Business Quant data, the three most recent Change in Accured Expenses figures were -$15.7 million in Q1 2026, $4.0 million in Q4 2025, and -$1.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Haleon 88.58 Bn 86.72 Bn - -
2 Teva Pharmaceutical Industries 35.90 Bn 32.16 Bn 1.97 Bn -144.00 Mn
3 Zoetis 32.33 Bn 30.39 Bn 1.62 Bn -234.00 Mn
4 Takeda Pharmaceutical 27.49 Bn 23.43 Bn 4.39 Bn -
5 United Therapeutics 23.14 Bn 20.99 Bn 648.10 Mn -12.70 Mn
6 RedHill Biopharma 20.53 Bn 20.53 Bn - -
7 Viatris 20.29 Bn 18.49 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.93 Bn 16.62 Bn 800.70 Mn -14.30 Mn
9 Elanco Animal Health 12.63 Bn 12.21 Bn 785.00 Mn -
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn -15.72 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -15.72 Mn
Mar 31, 2026 -15.72 Mn
Dec 31, 2025 4.04 Mn
Dec 31, 2025 4.04 Mn
Sep 30, 2025 -1.43 Mn
Sep 30, 2025 -1.43 Mn
Jun 30, 2025 939,000.00
Jun 30, 2025 939,000.00
Mar 31, 2025 -9.03 Mn
Mar 31, 2025 -9.03 Mn
Dec 31, 2024 -10.31 Mn
Dec 31, 2024 -10.31 Mn
Sep 30, 2024 -1.61 Mn
Sep 30, 2024 -1.61 Mn
Jun 30, 2024 3.29 Mn
Jun 30, 2024 3.29 Mn
Mar 31, 2024 -8.33 Mn
Mar 31, 2024 -8.33 Mn
Dec 31, 2023 26.00 Mn
Dec 31, 2023 26.00 Mn